Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Shanghai - Delayed Quote CNY

*ST NING KE (600165.SS)

Compare
4.5400
-0.2400
(-5.02%)
At close: 2:56:55 PM GMT+8
Loading Chart for 600165.SS
  • Previous Close 4.7800
  • Open 4.5400
  • Bid --
  • Ask 4.5400 x --
  • Day's Range 4.5400 - 4.6000
  • 52 Week Range 1.2600 - 4.8100
  • Volume 9,371,100
  • Avg. Volume 20,755,481
  • Market Cap (intraday) 3.109B
  • Beta (5Y Monthly) 1.11
  • PE Ratio (TTM) --
  • EPS (TTM) -0.7900
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date Jun 18, 2001
  • 1y Target Est --

Ningxia Zhongke Biotechnology Co., Ltd. produces and sells coal-based activated carbon and lauric acid products. The company was founded in 1998 and is based in Yinchuan, China.

www.xinrihengli.com

834

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 600165.SS

View More

Performance Overview: 600165.SS

Trailing total returns as of 4/7/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

600165.SS
86.83%
SSE Composite Index (000001.SS)
7.61%

1-Year Return

600165.SS
41.87%
SSE Composite Index (000001.SS)
0.89%

3-Year Return

600165.SS
51.29%
SSE Composite Index (000001.SS)
4.33%

5-Year Return

600165.SS
7.84%
SSE Composite Index (000001.SS)
9.78%

Compare To: 600165.SS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 600165.SS

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    3.27B

  • Enterprise Value

    3.49B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    9.48

  • Price/Book (mrq)

    45.60

  • Enterprise Value/Revenue

    10.12

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -156.06%

  • Return on Assets (ttm)

    -5.23%

  • Return on Equity (ttm)

    -211.44%

  • Revenue (ttm)

    345.32M

  • Net Income Avi to Common (ttm)

    -538.91M

  • Diluted EPS (ttm)

    -0.7900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    8.61M

  • Total Debt/Equity (mrq)

    282.00%

  • Levered Free Cash Flow (ttm)

    164.54M

Research Analysis: 600165.SS

View More

Company Insights: 600165.SS

Research Reports: 600165.SS

View More

People Also Watch